Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Avorn

Showing results (21-30 of 184) with videos related to

Pageof 19
Sort By:
European Heart Journal|March 27, 2002
Unhealthy ageing: functional and socioeconomic impactJ Avorn
The New England Journal of Medicine|May 17, 1984
Benefit and cost analysis in geriatric care. Turning age discrimination into health policyJ Avorn
Health Affairs (Project Hope)|January 1, 1986
Drug innovation and public policy: some speculationsJ Avorn
JAMA|April 4, 1990
Reporting drug side effects: signals and noiseJ Avorn
The New England Journal of Medicine|September 24, 1998
Depression in the elderly--falls and pitfallsJ Avorn
Pharmacoeconomics|December 10, 1991
Improving the quality and cost-effectiveness of prescribingJ Avorn
Health Affairs (Project Hope)|January 1, 1995
Medication use and the elderly: current status and opportunitiesJ Avorn
Journal of the American Geriatrics Society|March 1, 1983
Biomedical and social determinants of cognitive impairment in the elderlyJ Avorn
Journal of the American Geriatrics Society|June 1, 1982
Induced disability in nursing home patients: a controlled trialJ Avorn, E Langer
Clinics in Geriatric Medicine|November 1, 1996
Medications and falls. Causation, correlation, and preventionM Monane, J Avorn
Pageof 19

Showing results (21-30 of 184) with videos related to

Sort By:
Pageof 19
European Heart Journal|March 27, 2002
Unhealthy ageing: functional and socioeconomic impactJ Avorn
The New England Journal of Medicine|May 17, 1984
Benefit and cost analysis in geriatric care. Turning age discrimination into health policyJ Avorn
Health Affairs (Project Hope)|January 1, 1986
Drug innovation and public policy: some speculationsJ Avorn
JAMA|April 4, 1990
Reporting drug side effects: signals and noiseJ Avorn
The New England Journal of Medicine|September 24, 1998
Depression in the elderly--falls and pitfallsJ Avorn
Pharmacoeconomics|December 10, 1991
Improving the quality and cost-effectiveness of prescribingJ Avorn
Health Affairs (Project Hope)|January 1, 1995
Medication use and the elderly: current status and opportunitiesJ Avorn
Journal of the American Geriatrics Society|March 1, 1983
Biomedical and social determinants of cognitive impairment in the elderlyJ Avorn
Journal of the American Geriatrics Society|June 1, 1982
Induced disability in nursing home patients: a controlled trialJ Avorn, E Langer
Clinics in Geriatric Medicine|November 1, 1996
Medications and falls. Causation, correlation, and preventionM Monane, J Avorn
Pageof 19